Metabolic raises a strategic round of funding to fuel global expansion

Metabolic, the parent company of GluCare.Health and Zone.Health, announced that it has secured a new strategic growth capital facility in partnership with RAKBANK. This funding, comprising both debt and equity from the founders, will help the company scale its hybrid care model from its base in the UAE into major healthcare markets such as the United Kingdom and the United States. The goal is to make technology-enabled metabolic care more widely available and support continuous, outcomes-driven treatment rather than the traditional episodic healthcare approach.

The company says this funding comes at a time when metabolic health issues, like diabetes and obesity, pose a significant global health and economic challenge — costing more than $2 trillion per year worldwide and billions in the UAE alone. Metabolic's approach uses real-time data and multidisciplinary clinical teams to deliver continuous care, which it claims results in better outcomes than conventional methods. Metabolic's results have been validated and published by the New England Journal of Medicine Group, which the company highlights as evidence of its model's effectiveness.

This capital infusion marks a shift from Metabolic's prior self-funded strategy and represents a major step toward international expansion. Plans include opening a new flagship center in Dubai Digital Park, launching operations in Knightsbridge, London, and establishing select U.S. sites that combine in-person care with advanced monitoring technology. The company believes this strategy will help challenge existing healthcare norms and deliver superior care in some of the world's largest markets.